Liefeng Wang

755 total citations
26 papers, 596 citations indexed

About

Liefeng Wang is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Liefeng Wang has authored 26 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Liefeng Wang's work include Liver Disease Diagnosis and Treatment (4 papers), Extracellular vesicles in disease (2 papers) and Cancer Mechanisms and Therapy (2 papers). Liefeng Wang is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Extracellular vesicles in disease (2 papers) and Cancer Mechanisms and Therapy (2 papers). Liefeng Wang collaborates with scholars based in China, United States and Hong Kong. Liefeng Wang's co-authors include Minwen Xu, Xiaoli Zhang, Weiqiang Chen, Dong‐Ming Su, Weikan Wang, Xin Xie, Yucai Wang, Weiqiang Chen, Ye Cui and Wei Wei and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and The FASEB Journal.

In The Last Decade

Liefeng Wang

24 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liefeng Wang China 13 322 180 94 92 80 26 596
Qian Nie China 15 377 1.2× 118 0.7× 74 0.8× 68 0.7× 82 1.0× 62 616
Shu Zhuo China 15 326 1.0× 123 0.7× 91 1.0× 138 1.5× 62 0.8× 22 674
Xiaorui Yu China 15 429 1.3× 84 0.5× 81 0.9× 56 0.6× 46 0.6× 28 706
Xiao‐Jian Han China 17 538 1.7× 186 1.0× 63 0.7× 84 0.9× 44 0.6× 44 764
Chaoran Shi China 7 311 1.0× 94 0.5× 46 0.5× 107 1.2× 64 0.8× 14 626
Haymo Pircher Austria 16 379 1.2× 94 0.5× 182 1.9× 90 1.0× 195 2.4× 23 700
Matthew D. Streeter United States 7 317 1.0× 119 0.7× 70 0.7× 44 0.5× 41 0.5× 15 536
Zhongping Su China 13 388 1.2× 115 0.6× 71 0.8× 65 0.7× 136 1.7× 20 736
Lauren DeVine United States 11 560 1.7× 244 1.4× 82 0.9× 40 0.4× 75 0.9× 27 821
Soo Youn Choi South Korea 18 431 1.3× 107 0.6× 139 1.5× 104 1.1× 170 2.1× 35 878

Countries citing papers authored by Liefeng Wang

Since Specialization
Citations

This map shows the geographic impact of Liefeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liefeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liefeng Wang more than expected).

Fields of papers citing papers by Liefeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liefeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liefeng Wang. The network helps show where Liefeng Wang may publish in the future.

Co-authorship network of co-authors of Liefeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Liefeng Wang. A scholar is included among the top collaborators of Liefeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liefeng Wang. Liefeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Xiaohan, et al.. (2025). Antitumor activity of gilteritinib, an inhibitor of AXL, in human solid tumors. Cell Death Discovery. 11(1). 124–124. 1 indexed citations
2.
Zhou, Dongdong, Erjiang Tang, Wenjun Wang, et al.. (2025). Combined therapy with DR5-targeting antibody-drug conjugate and CDK inhibitors as a strategy for advanced colorectal cancer. Cell Reports Medicine. 6(6). 102158–102158. 3 indexed citations
3.
4.
Liu, Hongfu, Dongdong Zhou, Kai Zhang, et al.. (2024). Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer. Cell Death and Disease. 15(3). 187–187. 12 indexed citations
5.
Li, Weisong, Kai Zhang, Wenjun Wang, et al.. (2024). Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 56–56. 10 indexed citations
6.
Xu, Minwen, et al.. (2024). Effects of mitochondrial dysfunction on cellular function: Role in atherosclerosis. Biomedicine & Pharmacotherapy. 174. 116587–116587. 20 indexed citations
7.
Zheng, Chao, Dongdong Zhou, Weisong Li, et al.. (2023). Therapeutic efficacy of a MMAE-based anti-DR5 drug conjugate Oba01 in preclinical models of pancreatic cancer. Cell Death and Disease. 14(4). 295–295. 17 indexed citations
8.
Wu, Choufei, Shuzhen Li, Liefeng Wang, et al.. (2020). Mitochondrial Fusion Machinery Specifically Involved in Energy Deprivation-Induced Autophagy. Frontiers in Cell and Developmental Biology. 8. 221–221. 11 indexed citations
9.
Chen, Weiqiang, Xiaoli Zhang, Minwen Xu, et al.. (2020). Betaine prevented high-fat diet-induced NAFLD by regulating the FGF10/AMPK signaling pathway in ApoE−/− mice. European Journal of Nutrition. 60(3). 1655–1668. 49 indexed citations
10.
Zhong, Zilin, et al.. (2019). Seven novel variants expand the spectrum of RPE65-related Leber congenital amaurosis in the Chinese population.. SHILAP Revista de lepidopterología. 25. 204–214. 15 indexed citations
11.
Zhang, Xiaoli, et al.. (2019). The role of long noncoding RNA in major human disease. Bioorganic Chemistry. 92. 103214–103214. 148 indexed citations
12.
Xu, Minwen, et al.. (2018). MicroRNA Functions in Thymic Biology: Thymic Development and Involution. Frontiers in Immunology. 9. 2063–2063. 20 indexed citations
13.
Wang, Weikan, Liefeng Wang, Linhui Ruan, et al.. (2018). Extracellular vesicles extracted from young donor serum attenuate inflammaging via partially rejuvenating aged T‐cell immunotolerance. The FASEB Journal. 32(11). 5899–5912. 59 indexed citations
14.
Wang, Weikan, Liefeng Wang, Jiyoung Oh, Qichuan Zhuge, & Dong‐Ming Su. (2017). Young serum-derived exosomes potentially attenuate inflammaging via partially rejuvenating immuotolerance (Supported by NIH/NIAID R01AI121147 to D-M. S.). The Journal of Immunology. 198(Supplement_1). 215.22–215.22. 1 indexed citations
15.
Xu, Minwen, Olga Sizova, Liefeng Wang, & Dong‐Ming Su. (2017). A Fine-Tune Role of Mir-125a-5p on Foxn1 During Age-Associated Changes in the Thymus. Aging and Disease. 8(3). 277–277. 21 indexed citations
16.
Xu, Minwen, et al.. (2017). MicroRNAs Regulate Thymic Epithelium in Age-Related Thymic Involution via Down- or Upregulation of Transcription Factors. Journal of Immunology Research. 2017. 1–9. 9 indexed citations
17.
Coder, Brandon, Weikan Wang, Liefeng Wang, et al.. (2016). Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during aging. Oncotarget. 8(4). 7116–7137. 31 indexed citations
18.
19.
Wang, Liefeng, Ru Zhang, & Xin Xie. (2009). Development of a High-Throughput Assay for Screening of γ-Secretase Inhibitor with Endogenous Human, Mouse or Drosophila γ-Secretase. Molecules. 14(9). 3589–3599. 10 indexed citations
20.
Zhang, Ge, Liefeng Wang, Huaqiao Wang, & Zhibin Yao. (2005). [Fusion expression of human Abeta42 recombinant protein and detection of Abeta antibody].. PubMed. 25(2). 160–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qian Nie Breakdown of academic impact, for papers by Shu Zhuo Breakdown of academic impact, for papers by Xiaorui Yu Breakdown of academic impact, for papers by Xiao‐Jian Han Breakdown of academic impact, for papers by Chaoran Shi Breakdown of academic impact, for papers by Haymo Pircher Breakdown of academic impact, for papers by Matthew D. Streeter Breakdown of academic impact, for papers by Zhongping Su Breakdown of academic impact, for papers by Lauren DeVine Breakdown of academic impact, for papers by Soo Youn Choi
Rankless by CCL
2026